HR Execs on the Move

Soft Axis Inc

www.softaxis.net

 
Soft Axis Inc is a Norcross, GA-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Jacksonville Icemen

The Jacksonville Icemen are a minor league ice hockey team in the ECHL in Jacksonville, Florida, that began play in the 2017–18 season.

Boreal Access

Boreal Access is a Grand Marais, MN-based company in the Software and Internet sector.

MetaCommunications

MetaCommunications develops workflow and collaborative productivity solutions that automate marketing, brand management, creative design, packaging and prepress processes so organizations around the world can be more productive. With thousands of customer sites worldwide, we have the solid experience and range of solutions to quickly help your organization take its productivity to the next level through improved processes, workflows and communications. MetaCommunications produces its flagship product Workgroups DaVinci™, as either an on-premise installation or as a cloud-hosted solution. We also provide turnkey implementation, best practices consulting and training services.

RAVE Computer

RAVE Computer specializes in computer integration, multi-vendor integration, embedded & OEM, training, virtualization, federal intelligence and more.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.